TK
Tim Kutzkey
Tim Kutzkey
Tim Kutzkey insider trades: Eikon Therapeutics (EIKN) stock buys and sales
Eikon Therapeutics Last trade Sep 3, 2026 107 Form 4 filings
$5.9M
Sold, last 12 months
3 sales
$45.1M
Bought, last 12 months
14 buys
98
Open-market trades
since 2017
10
Companies
last trade 2026
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Tim reports to the SEC
EIKNEikon Therapeutics
Insider · last filing Sep 8, 2026
+$39.2M
TNYATenaya Therapeutics
Insider · last filing Feb 26, 2026
-$5.9M
SRZNSurrozen, Inc./DE
Insider · last filing Oct 22, 2026
+$9.0M
NGMNgm Biopharmaceuticals
10% Owner · last filing Apr 8, 2024
+$92.8M
RAPTRAPT Therapeutics
Insider · last filing Dec 23, 2024
-$44.7M
+$21.2M
NRIXNurix Therapeutics
10% Owner · last filing May 7, 2021
No market trades
and 4 more companies
Open-market buys and sales
98 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | EIKN | ↑ Buy | 89,200 | $11.56 | $1.0M | Indirect | Sep 8, 2026 (5d) |
| Feb 25, 2026 | TNYA | ↓ Sell | 4,170,266 | $0.57 | $2.4M | Indirect | Feb 26, 2026 (1d) |
| Feb 23, 2026 | TNYA | ↓ Sell | 829,734 | $0.61 | $505K | Indirect | Feb 24, 2026 (1d) |
| Feb 11, 2026 | TNYA | ↓ Sell | 4,400,290 | $0.69 | $3.0M | Indirect | Feb 12, 2026 (1d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 1,437,323 | $18.00 | $25.9M | By The Column Group IV, LP | Feb 9, 2026 (3d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 630,881 | $18.00 | $11.4M | By The Column Group Opportunity III, LP | Feb 9, 2026 (3d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 49,556 | $18.00 | $892K | By The Column Group IV-A, LP | Feb 9, 2026 (3d) |
| Jan 20, 2026 | SRZN | ↑ Buy | 17,229 | $19.74 | $340K | By The Column Group III-A, LP | Jan 20, 2026 (0d) |
| Jan 20, 2026 | SRZN | ↑ Buy | 15,278 | $19.74 | $302K | By The Column Group III, LP | Jan 20, 2026 (0d) |
| Jan 14, 2026 | SRZN | ↑ Buy | 9,536 | $19.86 | $189K | By The Column Group III-A, LP | Jan 15, 2026 (1d) |
| Jan 14, 2026 | SRZN | ↑ Buy | 8,457 | $19.86 | $168K | By The Column Group III, LP | Jan 15, 2026 (1d) |
| Jan 6, 2026 | SRZN | ↑ Buy | 8,003 | $19.89 | $159K | By The Column Group III-A, LP | Jan 8, 2026 (2d) |
| Jan 6, 2026 | SRZN | ↑ Buy | 7,097 | $19.89 | $141K | By The Column Group III, LP | Jan 8, 2026 (2d) |
| Dec 5, 2025 | SRZN | ↑ Buy | 19,172 | $19.22 | $369K | By The Column Group III-A, LP | Dec 8, 2025 (3d) |
| Dec 5, 2025 | SRZN | ↑ Buy | 16,978 | $19.22 | $326K | By The Column Group III, LP | Dec 8, 2025 (3d) |
| Nov 13, 2025 | SRZN | ↑ Buy | 167,307 | $12.65 | $2.1M | By The Column Group III-A, LP | Dec 2, 2025 (19d) |
| Nov 13, 2025 | SRZN | ↑ Buy | 148,150 | $12.65 | $1.9M | By The Column Group III, LP | Dec 2, 2025 (19d) |
| Apr 4, 2024 | SRZN | ↑ Buy | 102,651 | $15.50 | $1.6M | By The Column Group III-A, LP | Apr 8, 2024 (4d) |
| Apr 4, 2024 | SRZN | ↑ Buy | 90,897 | $15.50 | $1.4M | By The Column Group III, LP | Apr 8, 2024 (4d) |
| Nov 16, 2023 | NGM | ↑ Buy | 22,631 | $0.69 | $16K | Indirect | Nov 17, 2023 (1d) |
| Jan 31, 2023 | NGM | ↑ Buy | 184,272 | $5.00 | $921K | Indirect | Feb 1, 2023 (1d) |
| Jan 23, 2023 | NGM | ↑ Buy | 9,900 | $5.00 | $49K | Indirect | Jan 25, 2023 (2d) |
| Jan 20, 2023 | NGM | ↑ Buy | 38,139 | $5.00 | $191K | Indirect | Jan 23, 2023 (3d) |
| Jan 12, 2023 | NGM | ↑ Buy | 5,378 | $4.95 | $27K | Indirect | Jan 17, 2023 (5d) |
| Jan 11, 2023 | NGM | ↑ Buy | 309,070 | $4.79 | $1.5M | Indirect | Jan 12, 2023 (1d) |
| Dec 12, 2022 | NGM | ↑ Buy | 300 | $4.98 | $1K | Indirect | Dec 14, 2022 (2d) |
| Nov 22, 2022 | NGM | ↑ Buy | 40,327 | $5.00 | $202K | Indirect | Nov 23, 2022 (1d) |
| Nov 4, 2022 | NGM | ↑ Buy | 139,148 | $4.92 | $684K | Indirect | Nov 7, 2022 (3d) |
| Oct 27, 2022 | NGM | ↑ Buy | 76,877 | $4.86 | $374K | Indirect | Oct 31, 2022 (4d) |
| Oct 26, 2022 | NGM | ↑ Buy | 123,820 | $4.81 | $595K | Indirect | Oct 27, 2022 (1d) |
| Jun 9, 2022 | NGM | ↑ Buy | 984,161 | $13.50 | $13.3M | Indirect | Jun 13, 2022 (4d) |
| Jun 2, 2022 | NGM | ↑ Buy | 34,200 | $13.03 | $446K | Indirect | Jun 6, 2022 (4d) |
| Jun 1, 2022 | NGM | ↑ Buy | 153,806 | $13.46 | $2.1M | Indirect | Jun 2, 2022 (1d) |
| May 27, 2022 | NGM | ↑ Buy | 22,911 | $13.49 | $309K | Indirect | May 31, 2022 (4d) |
| May 25, 2022 | RAPT | ↑ Buy | 1,900 | $12.45 | $24K | Indirect | May 27, 2022 (2d) |
| May 25, 2022 | NGM | ↑ Buy | 61,120 | $13.42 | $820K | Indirect | May 26, 2022 (1d) |
| May 24, 2022 | RAPT | ↑ Buy | 26,550 | $12.19 | $324K | Indirect | May 25, 2022 (1d) |
| May 20, 2022 | NGM | ↑ Buy | 39,700 | $13.36 | $530K | Indirect | May 23, 2022 (3d) |
| May 18, 2022 | NGM | ↑ Buy | 151,699 | $13.33 | $2.0M | Indirect | May 19, 2022 (1d) |
| May 16, 2022 | NGM | ↑ Buy | 33,166 | $12.90 | $428K | Indirect | May 17, 2022 (1d) |
| May 12, 2022 | NGM | ↑ Buy | 166,350 | $11.43 | $1.9M | Indirect | May 13, 2022 (1d) |
| May 10, 2022 | RAPT | ↑ Buy | 1,250,000 | $10.67 | $13.3M | Indirect | May 12, 2022 (2d) |
| May 10, 2022 | NGM | ↑ Buy | 114,440 | $10.95 | $1.3M | Indirect | May 11, 2022 (1d) |
| Sep 27, 2021 | RAPT | ↓ Sell | 9,239 | $34.57 | $319K | Indirect | Sep 29, 2021 (2d) |
| Sep 15, 2021 | RAPT | ↓ Sell | 181,211 | $37.01 | $6.7M | Indirect | Sep 16, 2021 (1d) |
| Sep 13, 2021 | RAPT | ↓ Sell | 36,055 | $35.22 | $1.3M | Indirect | Sep 14, 2021 (1d) |
| Sep 2, 2021 | RAPT | ↓ Sell | 68,850 | $35.34 | $2.4M | Indirect | Sep 3, 2021 (1d) |
| Aug 24, 2021 | RAPT | ↓ Sell | 95,746 | $31.30 | $3.0M | Indirect | Aug 24, 2021 (0d) |
| Feb 17, 2021 | CNST | ↓ Sell | 10,000 | $36.95 | $370K | Indirect | Feb 19, 2021 (2d) |
| Nov 16, 2020 | RVMD | ↓ Sell | 1,075,133 | $36.40 | $39.1M | Indirect | Nov 18, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EIKN insiders
Open-market trades in the last 12 months
Column Group IV GP, LP
Insider
2 buys
Sep 3, 2026
Column Group Opportunity III GP, LP
Insider
2 buys
Sep 3, 2026
Column Group IV-A, LP
Insider
2 buys
Sep 3, 2026
Column Group IV, LP
Insider
2 buys
Sep 3, 2026
Column Group Opportunity III, LP
Insider
2 buys
Sep 3, 2026
TCG Opportunity III GP, LLC
Insider
2 buys
Sep 3, 2026
Peter Svennilson
Insider
2 buys
Sep 3, 2026
Foresite Capital Management IV, LLC
10% Owner
1 buy
Feb 4, 2026
About Tim Kutzkey's insider trades
Tim Kutzkey is an insider at Eikon Therapeutics (EIKN). Since Oct 27, 2017, Tim has reported 85 open-market purchases worth $186.0M and 13 sales worth $124.8M on SEC Form 4. In the last 12 months: 14 buys ($45.1M) and 3 sales ($5.9M).
Their filings also include other transactions (9 filings), conversions (7 filings), grants and awards (6 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIKN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.